MedPath

Investigation of genetic predictors of the response to SSRI treatment in patients with panic disorder

Conditions
panic disorder
Registration Number
EUCTR2007-002649-19-EE
Lead Sponsor
Tartu University Hospital Psychiatry Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

To participate in the study, the subjects must be at least 18 years old and give a written informed consent after an oral and written explanation of the study aims and methods. The study sample will include at least 150 female and 150 male patients with PD diagnosis according to DSM-IV criteria with or without comorbid depression. The additional inclusion criteria will be at least moderate clinical severity, suitability to treatment with an SSRI
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

history of other psychiatric disorders, such as organic mental disorders, substance use disorders, psychotic disorders, bipolar disorder; serious somatic diseases; pregnancy

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath